US › Healthcare

Pro-Dex Inc (PDEX)

US · Healthcare · Medical Instruments & Supplies

$63.16+3.20%

Last close · 2026-11-06

Latest quarter · ended 2026-09-30

Revenue

$20.6M

Revenue YoY

+11.0%

Net profit

$3.0M

Profit YoY

-34.9%

EPS

$0.92

EPS estimate

$0.67

Net margin

14.8%

EPS came in at 0.92 against a street estimate of 0.67 — a beat of 37.3%.

Key statistics

Market cap

$199.2M

P/E

15.0

Forward P/E

20.4

P/B

4.28

Book value

$14.95

EPS (TTM)

$4.12

52-week high

$77.00

52-week low

$28.81

50-day MA

$64.93

200-day MA

$56.47

Beta

0.04

Analyst view

Analysts rate Pro-Dex Inc a strong buy (1 buy, 0 hold, 0 sell out of 1) with an average price target of $74.00.

Shareholding

Insiders

36.03%

Institutions

32.02%

Largest institutional holders

Fund	Stake
BlackRock Inc	4.74%
Vanguard Capital Management, LLC	2.54%
Dimensional Fund Advisors, Inc.	1.76%
Punch & Associates Inv Mgmt Inc	1.63%
Geode Capital Management, LLC	1.54%
JPMorgan Chase & Co	1.00%
State Street Corp	0.97%
The Goldman Sachs Group Inc	0.58%

See the full picture

Technicals, trade setups with a published hit rate, AI analysis and earnings-call summaries for Pro-Dex Inc — free to start.

Open in the app Google Play App Store

Other Healthcare companies

Eli Lilly and Company Johnson & Johnson AbbVie Inc Merck & Company Inc UnitedHealth Group Incorporated Novartis AG ADR AstraZeneca PLC Thermo Fisher Scientific Inc Amgen Inc Gilead Sciences Inc Abbott Laboratories Novo Nordisk A/S

Data updated 2026-11-07.